Arvinas, Inc. (ARVN) vs ProKidney Corp. (PROK)
Arvinas, Inc. and ProKidney Corp. are both Biotechnology companies. Arvinas, Inc. and ProKidney Corp. are of similar size ($514.0M and $509.4M). ProKidney Corp. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. Arvinas, Inc. has the higher net margin (2.94% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Arvinas, Inc. leads on 9 and ProKidney Corp. on 5.
Valuation
Profitability
| Metric | ARVN | PROK | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 100.00% | 65.16% |
| Operating margin | (5.72%) | (21,664.55%) | 0.00% |
| Net margin | 2.94% | (10,288.39%) | 0.00% |
| Free cash flow margin | (65.93%) | (17,300.61%) | 0.00% |
| Return on equity | 1.59% | 8.92% | (57.72%) |
| Return on assets | 1.17% | (27.10%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack